Clinical evaluation of the efficacy of the P2X7purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine (Q57231903)
Jump to navigation
Jump to search
scholarly article by Edward C Keystone et al published 10 September 2012 in Annals of the Rheumatic Diseases
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical evaluation of the efficacy of the P2X7purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine |
scholarly article by Edward C Keystone et al published 10 September 2012 in Annals of the Rheumatic Diseases |
Statements
Clinical evaluation of the efficacy of the P2X7purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine (English)
0 references
10 September 2012
0 references
71
0 references
1630-1635
0 references
10
0 references